Differential regulation of cyclo‐oxygenase‐2 and 5‐lipoxygenase‐activating protein (FLAP) expression by glucocorticoids in monocytic cells
- 1 October 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 122 (4) , 619-624
Abstract
The objective of the present study was to determine the effects of dexamethasone on key constituents of prostaglandin and leukotriene biosynthesis, cyclo‐oxygenase‐2 (COX‐2) and 5‐lipoxygenase activating protein (FLAP). The human monocytic cell line THP‐1 was used as a model system. mRNA and protein levels of COX‐2 and FLAP were determined by Northern and Western blot analyses, respectively. Low levels of COX‐2 and FLAP mRNA were expressed in undifferentiated THP‐1 cells, but were induced upon differentiation of the cells along the monocytic pathway by treatment with phorbol ester (TPA, 5 nM). Maximal expression was observed after two days. Coincubation of the undifferentiated cells with dexamethasone (10−9–10−6 M) and phorbol ester prevented induction of COX‐2 mRNA, but did not affect the induction of FLAP mRNA. Dexamethasone downregulated COX‐2 mRNA and protein in differentiated, monocyte‐like THP‐1 cells. In contrast, FLAP mRNA and protein were upregulated by dexamethasone in differentiated THP‐1 cells. After 24 h, FLAP mRNA levels were increased more than 2 fold. Dexamethasone did not change 5‐lipoxygenase mRNA expression. Release of prostaglandin E2 (PGE2) and peptidoleukotrienes was determined in cell culture supernatants of differentiated THP‐1 cells by ELISA. Calcium ionophore‐dependent PGE2 synthesis was associated with COX‐2 expression, whereas COX‐1 and COX‐2 seemed to participate in arachidonic acid‐dependent PGE2 synthesis. Very low levels of peptidoleukotrienes were released from differentiated THP‐1 cells upon incubation with ionophore. Treatment with dexamethasone did not significantly affect leukotriene release. These data provide evidence that prostaglandin synthesis is consistently downregulated by glucocorticoids. However, the glucocorticoid‐mediated induction of FLAP may provide a mechanism to maintain leukotriene biosynthesis through more efficient transfer of arachidonic acid to the 5‐lipoxygenase reaction, in spite of inhibitory effects on other enzymes of the biosynthetic pathway. British Journal of Pharmacology (1997) 122, 619–624; doi:10.1038/sj.bjp.0701425Keywords
This publication has 42 references indexed in Scilit:
- Two step purification of human and murine leukotriene C4 synthaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation.Journal of Clinical Investigation, 1995
- Prostaglandin endoperoxide synthase-1 and synthase-2 expression in differentiating human monocytic cellsInflammation Research, 1994
- Oxidized Low Density Lipoprotein Increases U937 Cell 5-Lipoxygenase Activity: Induction of 5-Lipoxygenase Activating ProteinBiochemical and Biophysical Research Communications, 1994
- Differentiation of Monocytoid THP-1 Cells with Phorbol Ester Induces Expression of Prostaglandin Endoperoxide Synthase-1 (COX-1)Biochemical and Biophysical Research Communications, 1993
- Differentiation‐associated expression of prostaglandin G/H synthase in monocytic cellsFEBS Letters, 1993
- 5‐lipoxygenase‐activating protein is an arachidonate binding proteinFEBS Letters, 1993
- Anti-inflammatory effects of glucocorticoids and cyclosporin A on human basophilsEuropean Journal of Clinical Pharmacology, 1993
- An overview of glucocorticoid anti-inflammatory actionsEuropean Journal of Clinical Pharmacology, 1993
- A monoclonal antibody against the sulfidopeptide leukotrienes LTC4, LTD4 and LTE4Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991